Agios Pharmaceuticals, Inc. (AGIO) has a consensus analyst rating of Buy, based on 29 analysts covering the stock. Of those, 22 recommend buying, 7 recommend holding, and 0 recommend selling.
The analyst consensus price target for AGIO is $41.50, representing a +24.6% upside from the current price of $33.3. Price targets range from a low of $25.00 to a high of $62.00.
